Metraipolis › archive › dc_4e6a1eb45d83

Tescalcin is a phagocytic checkpoint driving immune escape and limiting immunotherapeutic efficacy in hepatocellular carcinoma — Europe PMC PMID:41926218

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41926218
DOI
10.1172/jci200415
License (as archived)
solo-consultazione
Archived
2026-11-03T10:39:58.585Z
SHA-256 of the archived text
59082d7b2f3d4ff4a2bcc87568d81cfdc7245cb16a4e1c88031fa34db958ffcb
Stable URL of this page
https://metraipolis.com/documento/dc_4e6a1eb45d83

How to cite

Tescalcin is a phagocytic checkpoint driving immune escape and limiting immunotherapeutic efficacy in hepatocellular carcinoma — Europe PMC PMID:41926218 — Europe PMC (en), https://europepmc.org/article/MED/41926218 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e6a1eb45d83 (Metraipolis archive dc_4e6a1eb45d83, sha256 59082d7b2f3d4ff4a2bcc87568d81cfdc7245cb16a4e1c88031fa34db958ffcb)
BibTeX
@misc{dc4e6a1eb45d83,
  title = {Tescalcin is a phagocytic checkpoint driving immune escape and limiting immunotherapeutic efficacy in hepatocellular carcinoma — Europe PMC PMID:41926218},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41926218},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e6a1eb45d83; sha256 59082d7b2f3d4ff4a2bcc87568d81cfdc7245cb16a4e1c88031fa34db958ffcb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41926218. Agents can read the archived copy with the MCP tool read_document.